Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
Metab Brain Dis ; 29(1): 153-60, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24248636

RESUMEN

In the present study we developed a chemically induced experimental model for gestational hypermethioninemia in rats and evaluated in the offspring the activities of Na(+),K(+)-ATPase and Mg(2+)-ATPase, as well as oxidative stress parameters, namely sulfhydryl content, thiobarbituric acid-reactive substances and the antioxidant enzymes superoxide dismutase and catalase in encephalon. Serum and encephalon levels of methionine and total homocysteine were also evaluated in mother rats and in the offspring. Pregnant Wistar rats received two daily subcutaneous injections of methionine throughout the gestational period (21 days). During the treatment, a group of pregnant rats received dose 1 (1.34 µmol methionine/g body weight) and the other one received dose 2 (2.68 µmol methionine/g body weight). Control group received saline. After the rats give birth, a first group of pups was killed at the 7th day of life and the second group at the 21th day of life for removal of serum and encephalon. Mother rats were killed at the 21th day postpartum for removal of serum and encephalon. Both doses 1 and 2 increased methionine levels in encephalon of the mother rats and dose 2 increased methionine levels in encephalon of the offspring. Maternal hypermethioninemia also decreased the activities of Na(+),K(+)-ATPase, Mg(2+)-ATPase and catalase, as well as reduced total sulfhydryl content in the encephalon of the pups. This chemical model seems to be appropriate for studies aiming to investigate the effect of maternal hypermethioninemia on the developing brain during gestation in order to clarify possible neurochemical changes in the offspring.


Asunto(s)
Errores Innatos del Metabolismo de los Aminoácidos/metabolismo , Encéfalo/enzimología , ATPasa de Ca(2+) y Mg(2+)/metabolismo , Modelos Animales de Enfermedad , Glicina N-Metiltransferasa/deficiencia , Proteínas del Tejido Nervioso/metabolismo , Complicaciones del Embarazo/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Errores Innatos del Metabolismo de los Aminoácidos/inducido químicamente , Animales , Animales Recién Nacidos , Encéfalo/embriología , Química Encefálica , Catalasa/análisis , Femenino , Glicina N-Metiltransferasa/metabolismo , Homocisteína/análisis , Intercambio Materno-Fetal , Metionina/análisis , Metionina/toxicidad , Oxidación-Reducción , Estrés Oxidativo , Embarazo , Complicaciones del Embarazo/inducido químicamente , Ratas , Ratas Wistar , Compuestos de Sulfhidrilo/análisis , Superóxido Dismutasa/análisis , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis
2.
Int J Dev Neurosci ; 29(7): 693-9, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21704148

RESUMEN

The purpose of this study was to develop a chronic chemically induced model of mild hyperhomocysteinemia in adult rats. We produced levels of Hcy in the blood (30µM), comparable to those considered a risk factor for the development of neurological and cardiovascular diseases, by injecting homocysteine subcutaneously (0.03µmol/g of body weight) twice a day, from the 30th to the 60th postpartum day. Controls received saline in the same volumes. Using this model, we evaluated the effect of chronic administration of homocysteine on redox status in the blood and cerebral cortex of adult rats. Reactive oxygen species and thiobarbituric acid reactive substances were significantly increased in the plasma and cerebral cortex, while nitrite levels were reduced in the cerebral cortex, but not in the plasma, of rats subjected to chronic mild hyperhomocysteinemia. Homocysteine was also seen to disrupt enzymatic and non-enzymatic antioxidant defenses in the blood and cerebral cortex of rats. Since experimental animal models are useful for understanding the pathophysiology of human diseases, the present model of mild hyperhomocysteinemia may be useful for the investigation of additional mechanisms involved in tissue alterations caused by homocysteine.


Asunto(s)
Modelos Animales de Enfermedad , Homocisteína/administración & dosificación , Homocisteína/farmacología , Hiperhomocisteinemia/inducido químicamente , Estrés Oxidativo/efectos de los fármacos , Animales , Antioxidantes/metabolismo , Catalasa/metabolismo , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Glutatión Peroxidasa/metabolismo , Homocisteína/sangre , Humanos , Nitritos/metabolismo , Oxidación-Reducción , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
3.
J Neural Transm (Vienna) ; 117(9): 1067-76, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20686907

RESUMEN

Depressive disorders, including major depression, are serious and disabling, whose mechanisms are not clearly understood. Since life stressors contribute in some fashion to depression, chronic variable stress (CVS) has been used as an animal model of depression. In the present study we evaluated some parameters of oxidative stress [thiobarbituric acid reactive substances (TBARS), catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx)], and inflammatory markers (interleukin 6, C reactive protein, tumor necrosis factor-alpha and nitrites), as well as the activity of butyrylcholinesterase in blood of rats subjected to chronic stress. Homocysteine and folate levels also were measured. Stressed animals were submitted to different mild stressors for 40 days. After CVS, a reduction in weight gain was observed in the stressed group, as well as an increase in immobility time in the forced swimming test as compared with controls. Stressed animals presented a significant increase on TBARS and SOD/CAT ratio, but stress did not alter GPx activity and any inflammatory parameters studied. CVS caused a significant inhibition on serum butyrylcholinesterase activity. Stressed rats had higher plasmatic levels of homocysteine without differences in folate levels. Although it is difficult to extrapolate our findings to the human condition, the alterations observed in this work may be useful to help to understand, at least in part, the pathophysiology of depressive disorders.


Asunto(s)
Butirilcolinesterasa/metabolismo , Depresión/metabolismo , Estrés Oxidativo/fisiología , Estrés Fisiológico/fisiología , Estrés Psicológico/metabolismo , Animales , Proteína C-Reactiva/metabolismo , Catalasa/sangre , Glutatión Peroxidasa/sangre , Inmunoensayo , Interleucina-6/sangre , Masculino , Ratas , Ratas Wistar , Superóxido Dismutasa/sangre , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Factor de Necrosis Tumoral alfa/sangre
4.
Metab Brain Dis ; 18(2): 129-37, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12822831

RESUMEN

Hypertryptophanemia is a rare inherited metabolic disorder probably caused by a blockage in the conversion of tryptophan to kynurenine, accumulating tryptophan and some of its metabolites in plasma and tissues of affected patients. The patients present mild to moderate mental retardation with exaggerated affective responses, periodic mood swings, and apparent hypersexual behavior. Pyruvate kinase catalyses a critical step in the glycolysis pathway, the main route that provides energy to brain functioning. The main objective of the present study was to determine pyruvate kinase activity in brain cortex of rats subjected to acute chemically induced hypertryptophanemia. The effect of alanine administration to the treated rats on the enzyme activity was also investigated. We also studied the in vitro effect of the two amino acids on pyruvate kinase activity in the brain cortex of nontreated rats. The results indicated that tryptophan inhibits pyruvate kinase in vitro and in vivo and that alanine prevents this inhibitory effect on the enzyme activity. Considering the crucial role pyruvate kinase plays in glucose metabolism in brain, it is possible that inhibition of this enzyme activity may contribute to the brain damage characteristic of this disease. Further studies will be necessary to evaluate possible benefits of alanine administration to the patients affected by hypertryptophanemia.


Asunto(s)
Alanina/farmacología , Corteza Cerebral/enzimología , Inhibidores Enzimáticos/farmacología , Piruvato Quinasa/antagonistas & inhibidores , Triptófano/antagonistas & inhibidores , Triptófano/farmacología , Animales , Corteza Cerebral/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Proteínas del Tejido Nervioso/metabolismo , Ratas , Ratas Wistar , Triptófano/sangre
5.
Brain Res ; 968(2): 281-4, 2003 Apr 11.
Artículo en Inglés | MEDLINE | ID: mdl-12663099

RESUMEN

Diabetic rats are more immobile during the forced-swimming test (FST) and GABAergic drugs reverse this behavior. We investigated if there is in vivo changes of GABA levels of diabetic rats during the FST. In vivo basal striatal GABA levels of streptozotocin diabetic rats are similar to non-diabetic rats. Non-diabetic rats presented a significant increase in GABA levels after the FST while the increase was delayed and lower in diabetic rats. These results suggest that diabetes may change GABA homeostasis and modify behavioral responses in an animal model of depression.


Asunto(s)
Diabetes Mellitus/metabolismo , Espacio Extracelular/metabolismo , Natación , Ácido gamma-Aminobutírico/metabolismo , Animales , Antibacterianos/efectos adversos , Conducta Animal , Diabetes Mellitus/inducido químicamente , Diabetes Mellitus/fisiopatología , Modelos Animales de Enfermedad , Masculino , Microdiálisis/métodos , Ratas , Ratas Wistar , Estreptozocina
6.
Folha méd ; 114(1): 59-63, jan.-mar. 1997. ilus
Artículo en Portugués | LILACS | ID: lil-197987

RESUMEN

Nesta revisäo da etiologia e patogênese da dermatite atópica, os autores estudaram os vários aspectos desta manifestaçäo complexa e multifatorial em especial predisposiçäo genética e anormalidades imunológicas centralizadas em uma disfunçäo dos T-linfócitos helper e supressor, produçäo de níveis altos de IgE, imunidade celular deprimida e liberaçäo de mediadores químicos de mastócitos e basófilos com a ativaçäo de células inflamatórias e interleucinas, resultando em inflamaçäo crônica local e em hiperreatividade cutânea observada nestes pacientes


Asunto(s)
Humanos , Dermatitis Atópica/etiología , Dermatitis Atópica/genética , Dermatitis Atópica/inmunología , Dermatitis Atópica/patología , Formación de Anticuerpos , Sistema Nervioso Autónomo , Inmunidad Celular , Factores Desencadenantes , Infecciones Estafilocócicas
7.
An. Acad. Nac. Med ; 153(1): 23-7, jan.-mar. 1993. ilus
Artículo en Portugués | LILACS | ID: lil-141925

RESUMEN

Nesta revisäo da etiologia e patogênese da Dermatite Atópica, os autores estudaram os vários aspectos desta manifestaçäo complexa e multifatorial, em especial predisposiçäo genética e anormalidades imunológicas centralizadas em uma disfunçäo dos T-linfócitos helper e supressor, produçäo de níveis altos de IgE, imunidade celular deprimida e liberaçäo de mediadores químicos de mastócitos e basófilos, com a ativaçäo de células inflamatórias e interleucinas, resultado em inflamaçäo crônica local e em hiperreatividade cutânea observada nestes pacientes


Asunto(s)
Humanos , Dermatitis Atópica/etiología , Dermatitis Atópica/genética , Dermatitis Atópica/inmunología , Inmunoglobulina E/inmunología , Linfocitos T/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA